Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
Saved in:
| Title: | Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). |
|---|---|
| Authors: | Gibofsky A; Hospital for Special Surgery, New York, NY, USA., Cannon GW; Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, USA., Harrison DJ; Amgen Inc., Thousand Oaks, CA, USA., Joseph GJ; Amgen Inc., Thousand Oaks, CA, USA., Bitman B; Amgen Inc., Thousand Oaks, CA, USA., Chaudhari S; KForce Clinical Research, Tampa, FL, USA., Collier DH; Amgen Inc., Thousand Oaks, CA, USA. |
| Source: | Clinical and experimental rheumatology [Clin Exp Rheumatol] 2015 May-Jun; Vol. 33 (3), pp. 297-301. Date of Electronic Publication: 2015 Feb 18. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25738333 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gibofsky+A%22">Gibofsky A</searchLink>; Hospital for Special Surgery, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cannon+GW%22">Cannon GW</searchLink>; Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+DJ%22">Harrison DJ</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Joseph+GJ%22">Joseph GJ</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bitman+B%22">Bitman B</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhari+S%22">Chaudhari S</searchLink>; KForce Clinical Research, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Collier+DH%22">Collier DH</searchLink>; Amgen Inc., Thousand Oaks, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228308521%22">Clinical and experimental rheumatology</searchLink> [Clin Exp Rheumatol] 2015 May-Jun; Vol. 33 (3), pp. 297-301. <i>Date of Electronic Publication: </i>2015 Feb 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clinical+And+Experimental+Rheumatology+S%2EA%2ES%22">Clinical And Experimental Rheumatology S.A.S </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>8308521 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0392-856X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220392856X%22">0392856X </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Rheumatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25738333 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 297 Titles: – TitleFull: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gibofsky A – PersonEntity: Name: NameFull: Cannon GW – PersonEntity: Name: NameFull: Harrison DJ – PersonEntity: Name: NameFull: Joseph GJ – PersonEntity: Name: NameFull: Bitman B – PersonEntity: Name: NameFull: Chaudhari S – PersonEntity: Name: NameFull: Collier DH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2015 May-Jun Type: published Y: 2015 Identifiers: – Type: issn-print Value: 0392-856X Numbering: – Type: volume Value: 33 – Type: issue Value: 3 Titles: – TitleFull: Clinical and experimental rheumatology Type: main |
| ResultId | 1 |
